Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000067 USD | -33.00% | -.--% | -.--% |
2015 | RBC Life Sciences, Inc. Approves Resignation of Robert A. Kaiser as a Director | CI |
2015 | Tranche Update on RBC Life Sciences Inc.'s Equity Buyback Plan announced on August 28, 2013. | CI |
Business Summary
Number of employees: 89
Sales per Business
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
Nutritional Products
59.5
%
| 17 | 69.9 % | 15 | 59.5 % | -10.03% |
Medical Products
40.5
%
| 7 | 30.1 % | 10 | 40.5 % | +42.57% |
Sales per region
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
United States
48.4
%
| 10 | 40.1 % | 12 | 48.4 % | +27.84% |
Southeast Asia
27.2
%
| 7 | 28.1 % | 7 | 27.2 % | +2.30% |
Russia/Eastern Europe
21.7
%
| 7 | 27.6 % | 6 | 21.7 % | -16.91% |
Canada
2.2
%
| 1 | 3.2 % | 1 | 2.2 % | -26.30% |
All Others
0.5
%
| 0 | 1.1 % | 0 | 0.5 % | -49.61% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ambrose Egbuonu
PSD | President | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ambrose Egbuonu
PSD | President | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,213,010 | 2,029,010 ( 91.69 %) | 0 | 91.69 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-.--% | 148 | |
-.--% | 843M | |
+0.79% | 655M | |
+11.31% | 407M | |
+36.41% | 254M | |
0.00% | 134M | |
+110.87% | 58.71M |
- Stock Market
- Equities
- RBCL Stock
- Company RBC Life Sciences, Inc.